Literature DB >> 32838651

Traumatic Brain Injury and Alcohol Drinking Alter Basolateral Amygdala Endocannabinoids in Female Rats.

Zachary F Stielper1,2, Elizabeth A Fucich1,2,3, Jason W Middleton2,4, Cecilia J Hillard5, Scott Edwards1,2, Patricia E Molina1,2, Nicholas W Gilpin1,2,6.   

Abstract

Traumatic brain injury (TBI) affects approximately 3 million Americans yearly and increases vulnerability to developing psychiatric comorbidities. Alcohol use disorder (AUD) is the most prevalent psychiatric diagnosis preceding injury and TBI may increase subsequent alcohol use. The basolateral amygdala (BLA) is a limbic structure commonly affected by TBI that is implicated in anxiety and AUD. Endocannabinoids (eCBs) regulate synaptic activity in the BLA, and BLA eCB modulation alters anxiety-like behavior and stress reactivity. Previous work from our laboratories showed that systemic eCB degradation inhibition ameliorates TBI-induced increases in anxiety-like behavior and motivation to respond for alcohol in male rats. Here, we used a lateral fluid percussion model to test moderate TBI effects on anxiety-like behavior, alcohol drinking, and eCB levels and cell signaling in BLA, as well as the effect of alcohol drinking on anxiety-like behavior and the BLA eCB system, in female rats. Our results show that TBI does not promote escalation of operant alcohol self-administration or increase anxiety-like behavior in female rats. In the BLA, TBI and alcohol drinking alter tissue amounts of 2-arachidonoylglycerol (2-AG) and N-arachidonoylethanolamine (anandamide; AEA) 1 h post-injury, and 2-AG levels remain low 11 days post-injury. Eleven days after injury, BLA pyramidal neurons were hyperexcitable, but measures of synaptic transmission and eCB signaling were unchanged. These data show that TBI impacts BLA 2-AG tissue levels, that this effect is modified by alcohol drinking, and also that TBI increases BLA cell excitability.

Entities:  

Keywords:  2-arachidonoylglycerol; anandamide; anxiety; electrophysiology; fluid percussion

Mesh:

Substances:

Year:  2020        PMID: 32838651      PMCID: PMC7875607          DOI: 10.1089/neu.2020.7175

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   4.869


  78 in total

1.  Diacylglycerol lipase β inhibition reverses nociceptive behaviour in mouse models of inflammatory and neuropathic pain.

Authors:  J L Wilkerson; S Ghosh; D Bagdas; B L Mason; M S Crowe; K L Hsu; L E Wise; S G Kinsey; M I Damaj; B F Cravatt; A H Lichtman
Journal:  Br J Pharmacol       Date:  2016-04-08       Impact factor: 8.739

Review 2.  The central amygdala as an integrative hub for anxiety and alcohol use disorders.

Authors:  Nicholas W Gilpin; Melissa A Herman; Marisa Roberto
Journal:  Biol Psychiatry       Date:  2014-09-22       Impact factor: 13.382

3.  Short-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerol.

Authors:  Marina Rubio; Douglas McHugh; Javier Fernández-Ruiz; Heather Bradshaw; J Michael Walker
Journal:  Neurosci Lett       Date:  2007-06-02       Impact factor: 3.046

4.  Endocannabinoid degradation inhibition improves neurobehavioral function, blood-brain barrier integrity, and neuroinflammation following mild traumatic brain injury.

Authors:  Paige S Katz; Jesse K Sulzer; Renata A Impastato; Sophie X Teng; Emily K Rogers; Patricia E Molina
Journal:  J Neurotrauma       Date:  2014-12-19       Impact factor: 5.269

Review 5.  The Endocannabinoid Signaling System in the CNS: A Primer.

Authors:  Cecilia J Hillard
Journal:  Int Rev Neurobiol       Date:  2015-11-06       Impact factor: 3.230

Review 6.  Amygdala and bed nucleus of the stria terminalis circuitry: Implications for addiction-related behaviors.

Authors:  Alice M Stamatakis; Dennis R Sparta; Joshua H Jennings; Zoe A McElligott; Heather Decot; Garret D Stuber
Journal:  Neuropharmacology       Date:  2013-06-07       Impact factor: 5.250

7.  BLA to vHPC inputs modulate anxiety-related behaviors.

Authors:  Ada C Felix-Ortiz; Anna Beyeler; Changwoo Seo; Christopher A Leppla; Craig P Wildes; Kay M Tye
Journal:  Neuron       Date:  2013-08-21       Impact factor: 17.173

8.  Endocannabinoid degradation inhibitors ameliorate neuronal and synaptic alterations following traumatic brain injury.

Authors:  Elizabeth A Fucich; Zachary F Stielper; Heather L Cancienne; Scott Edwards; Nicholas W Gilpin; Patricia E Molina; Jason W Middleton
Journal:  J Neurophysiol       Date:  2020-01-08       Impact factor: 2.974

9.  DAGLβ inhibition perturbs a lipid network involved in macrophage inflammatory responses.

Authors:  Ku-Lung Hsu; Katsunori Tsuboi; Alexander Adibekian; Holly Pugh; Kim Masuda; Benjamin F Cravatt
Journal:  Nat Chem Biol       Date:  2012-10-28       Impact factor: 15.040

10.  Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis.

Authors:  Matthew N Hill; Ryan J McLaughlin; Anna C Morrish; Victor Viau; Stan B Floresco; Cecilia J Hillard; Boris B Gorzalka
Journal:  Neuropsychopharmacology       Date:  2009-08-26       Impact factor: 7.853

View more
  2 in total

1.  Brain Injury Effects on Neuronal Activation and Synaptic Transmission in the Basolateral Amygdala of Adult Male and Female Wistar Rats.

Authors:  Alejandra Jacotte-Simancas; Jason W Middleton; Zachary F Stielper; Scott Edwards; Patricia E Molina; Nicholas W Gilpin
Journal:  J Neurotrauma       Date:  2022-02-17       Impact factor: 5.269

Review 2.  Does Traumatic Brain Injury Cause Risky Substance Use or Substance Use Disorder?

Authors:  Christopher M Olsen; John D Corrigan
Journal:  Biol Psychiatry       Date:  2021-07-21       Impact factor: 13.382

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.